Duration and timing of bisphosphonate treatment as factors determining osteoblast mineralization
Background: Alendronate is a drug for the treatment of excessive bone resorption. Alendronate reduces osteoblast viability and mineralization in a dose-dependent manner. Other views of alendronate could affect mineralization. Therefore, the effects of timing and duration of alendronate treatment on...
Saved in:
| Main Author: | Somying Patntirapong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-09-01
|
| Series: | Journal of Oral Biology and Craniofacial Research |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2212426822000884 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Timing of geranylgeraniol addition increases osteoblast activities under alendronate condition
by: Harikarn Mungpayabarn, et al.
Published: (2021-07-01) -
Therapeutic potential of bisphosphonates - review of medical indications, mechanism of action, interactions and adverse effects
by: Agnieszka Mikosińska, et al.
Published: (2025-01-01) -
G protein-coupled receptor 91 activations suppressed mineralization in Porphyromonas gingivalis–infected osteoblasts
by: Wenqi Su, et al.
Published: (2024-11-01) -
Murine vs. Human Osteoblast Responses to Coagulation and Inflammatory Factors: Reconsidering the Use of Animal Models in Hemophilia a Research
by: Aline Bernar, et al.
Published: (2024-11-01) -
Bisphosphonate-associated jaw osteonecrosis in the treatment of rheumatoid arthritis
by: Gabriela Dias Rosso dos Santos, et al.
Published: (2024-11-01)